| Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non–small-cell lung cancer F Cappuzzo, FR Hirsch, E Rossi, S Bartolini, GL Ceresoli, L Bemis, ... Journal of the National Cancer Institute 97 (9), 643-655, 2005 | 1961 | 2005 |
| EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues MP Martelli, G Sozzi, L Hernandez, V Pettirossi, A Navarro, D Conte, ... The American journal of pathology 174 (2), 661-670, 2009 | 411 | 2009 |
| How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene … A Patriti, MC Aisa, C Annetti, A Sidoni, F Galli, I Ferri, N Gullà, A Donini Surgery 142 (1), 74-85, 2007 | 250 | 2007 |
| Breast cancer in young women: clinicopathological features and biological specificity A Sidoni, A Cavaliere, G Bellezza, M Scheibel, E Bucciarelli The Breast 12 (4), 247-250, 2003 | 211 | 2003 |
| Central nervous system metastases in HER-2–positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors S Gori, S Rimondini, V De Angelis, M Colozza, G Bisagni, G Moretti, ... The Oncologist 12 (7), 766-773, 2007 | 187 | 2007 |
| Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype M Rugge, G Busatto, M Cassaro, YH Shiao, V Russo, G Leandro, ... Cancer 85 (12), 2506-2511, 1999 | 169 | 1999 |
| Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival V Ludovini, S Gori, M Colozza, L Pistola, E Rulli, I Floriani, E Pacifico, ... Annals of oncology 19 (5), 883-890, 2008 | 166 | 2008 |
| Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size … S Rossi, R Miceli, L Messerini, I Bearzi, G Mazzoleni, C Capella, ... The American journal of surgical pathology 35 (11), 1646-1656, 2011 | 158 | 2011 |
| Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor‐1 is associated with breast cancer progression: An immunohistochemical comparison … V Costantini, A Sidoni, R Deveglia, OA Cazzato, G Bellezza, I Ferri, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1996 | 155 | 1996 |
| High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in … V Ludovini, G Bellezza, L Pistola, F Bianconi, L Di Carlo, A Sidoni, ... Annals of oncology 20 (5), 842-849, 2009 | 144 | 2009 |
| Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice L Santucci, S Fiorucci, M Chiorean, PM Brunori, FM Di Matteo, A Sidoni, ... Gastroenterology 111 (3), 736-744, 1996 | 139 | 1996 |
| Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients V Ludovini, A Sidoni, L Pistola, G Bellezza, V De Angelis, S Gori, ... Breast cancer research and treatment 81, 159-168, 2003 | 130 | 2003 |
| Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity F Angiero, A Berenzi, A Benetti, E Rossi, R Del Sordo, A Sidoni, M Stefani, ... Anticancer research 28 (5A), 2535-2539, 2008 | 114 | 2008 |
| EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab S Gori, A Sidoni, M Colozza, I Ferri, MG Mameli, D Fenocchio, L Stocchi, ... Annals of oncology 20 (4), 648-654, 2009 | 104 | 2009 |
| Phase II study of weekly paclitaxel and trastuzumab in anthracycline-and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer S Gori, M Colozza, AM Mosconi, E Franceschi, C Basurto, R Cherubini, ... British journal of cancer 90 (1), 36-40, 2004 | 91 | 2004 |
| KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study S Rossi, D Gasparotto, R Miceli, L Toffolatti, G Gallina, E Scaramel, ... The American journal of surgical pathology 39 (7), 922-930, 2015 | 89 | 2015 |
| Primary breast lymphomas: a multicentric experience N Avenia, A Sanguinetti, R Cirocchi, G Bistoni, S Trastulli, F D'Ajello, ... World journal of surgical oncology 8, 1-4, 2010 | 89 | 2010 |
| Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells A Papi, T Guarnieri, G Storci, D Santini, C Ceccarelli, M Taffurelli, ... Cell Death & Differentiation 19 (7), 1208-1219, 2012 | 87 | 2012 |
| Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells S Beccafico, G Morozzi, MC Marchetti, C Riccardi, A Sidoni, R Donato, ... Carcinogenesis 36 (9), 1071-1083, 2015 | 84 | 2015 |
| Biological prognostic factors for early stage completely resected non–small cell lung cancer L Cagini, M Monacelli, G Giustozzi, L Moggi, G Bellezza, A Sidoni, ... Journal of surgical oncology 74 (1), 53-60, 2000 | 83 | 2000 |
